| E-Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Computers and Technology > Software > SearchInform 3.0 |
|
E-Articles - SearchInform 3.0
A solution to the problem of fuzziness of information content (using only one relevant document instead of a do According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product zen of its duplicates or similar documents from other sources). An information system may contain documents co ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in taining varying information from different sources. For instance: a database contains two or three similar docu lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ments that are practically identical in content, but with different headings and modifications in the text itse here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe f. A situation when one employee comments on one document and another comments on another document and so on an d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro d so forth. First of all, it’s double work (why comment twice or thrice on the same document?), second of all, ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc hen next used (if, say, the comments differ) part of the information may be uncalled for. SearchInform full te easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi xt search engine based on SoftInform Search Technology successfully solves the problem of information retrieval nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically thanks to its ability to conduct similar search and search identical text at the information indexing stage. M and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ain features of SearchInform 3.0: - Phrase search with due consideration to stemming and thesaurus - New ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi oftInform Search Technology of search for similar documents - High indexing speed (from 15 to 30 Gb/hour), ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a - Index size of 15-25% from the actual size of the text data - Query caching system - Support dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod f over 60 most popular text formats, Outlook & TheBat electronic messages, mp3 & avi tags, and logs of MSN and cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ICQ instant messaging programs - Correct work with archives - Universal data sources (indexing of DB tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen S) About SearchInform Technologies SearchInform Technologies was founded in 1995 and has been operating in th t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel e area of information technologies with special focus on information searching, storing and processing. The ran ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust e of company’s products is quite large and encompasses from mass production of single user-oriented products to y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ready business solutions to be integrated into corporate systems. Owing to its extensive experience in variou . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de projects, the company offers its services on developing custom information systems of any complexity. More in elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Erp System – How To Pick Right One Stock Certificates – Issuing Shares in a Corporation Consolidating Debt With Bad Credit Loans
|